Improving our visibility as a shared project by Teresa Bermejo Vicedo, Eduardo López-Briz

Get full text

Hospital pharmacist challenges in evaluation of scientific evidence and its incorporation to pharmacotherapeutic protocols through therapeutic committees in COVID-19 times by Cecilia M. Fernández-Llamazares, Eduardo López-Briz

Get full text

Bedaquiline in multidrug-resistant pulmonary tuberculosis GENESIS-SEFH drug evaluation report by Yolanda Borrego Izquierdo, Eduardo López Briz, Esther Márquez Saavedra

Get full text

Hazardous drugs: new challenges, new opportunities by Silvia Valero García, Eduardo López Briz, Nieves Vila Clérigues, Jose Luis Poveda Andrés

Get full text

Economic evaluation in collaborative hospital drug evaluation reports by Ana Ortega, María Dolores Fraga, Roberto Marín-Gil, Eduardo Lopez-Briz, Francesc Puigventós, George Dranitsaris

Get full text

Drug evaluation is also a clinical activity by Eduardo López-Briz, Mª Dolores Fraga-Fuentes, Ana Clopés-Estela, Ana Ortega-Eslava, Emilio Jesús Alegre-del Rey

Get full text

Review of oritavancin for the treatment of acute bacterial skin and skin structure infections by Ana Alejandra García Robles, Eduardo López Briz, María Dolores Fraga Fuentes, Rocío Asensi Diez, Jesús Francisco Sierra Sánchez

Get full text

Applying dose banding to the production of antineoplastic drugs: a narrative review of the literature by Pablo Pérez Huertas, Margarita Cueto Sola, Paloma Escobar Cava, Carmela Borrell García, Asunción Albert Marí, Eduardo López Briz, José Luis Poveda Andrés

Get full text